159 related articles for article (PubMed ID: 29625390)
1. Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3.
Wang M; Liu C; Bond A; Yang J; Zhou X; Wang J; Ji B
Int Immunopharmacol; 2018 Jun; 59():53-60. PubMed ID: 29625390
[TBL] [Abstract][Full Text] [Related]
2. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
[TBL] [Abstract][Full Text] [Related]
3. Tim3
Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
[TBL] [Abstract][Full Text] [Related]
4. Patients with intracranial aneurysms presented defects in regulatory T cells, which were associated with impairment in Tim-3 upregulation.
Zhang HF; Liang GB; Zhao MG; Zhao GF; Luo YH
Int Immunopharmacol; 2018 Nov; 64():350-355. PubMed ID: 30243071
[TBL] [Abstract][Full Text] [Related]
5. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
6. Higher frequency of peripheral blood follicular regulatory T cells in patients with new onset ankylosing spondylitis.
Shan Y; Qi C; Zhao J; Liu Y; Gao H; Zhao D; Ding F; Wang J; Jiang Y
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):154-61. PubMed ID: 25345823
[TBL] [Abstract][Full Text] [Related]
7. Functional defects in CD4
Guo H; Zheng M; Zhang K; Yang F; Zhang X; Han Q; Chen ZN; Zhu P
Sci Rep; 2016 Nov; 6():37559. PubMed ID: 27901054
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment.
Liao HT; Lin YF; Tsai CY; Chou CT
Joint Bone Spine; 2015 Dec; 82(6):423-7. PubMed ID: 26188878
[TBL] [Abstract][Full Text] [Related]
9. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
10. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
[TBL] [Abstract][Full Text] [Related]
11. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
12. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis.
Li M; Zhou X; Zhou L; Yu Z; Fu L; Yang P
Biomed Res Int; 2020; 2020():8709804. PubMed ID: 32149142
[TBL] [Abstract][Full Text] [Related]
14. Helios serves as a suppression marker to reduce regulatory T cell function in pancreatic cancer patients.
Liu MF; Jin C; Wu T; Chen EH; Lu M; Qin HL
Immunol Res; 2021 Jun; 69(3):275-284. PubMed ID: 33959834
[TBL] [Abstract][Full Text] [Related]
15. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
16. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.
Santner-Nanan B; Peek MJ; Khanam R; Richarts L; Zhu E; Fazekas de St Groth B; Nanan R
J Immunol; 2009 Dec; 183(11):7023-30. PubMed ID: 19915051
[TBL] [Abstract][Full Text] [Related]
17. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
18. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
[TBL] [Abstract][Full Text] [Related]
19. The immune dysfunction in ankylosing spondylitis patients.
Duan Z; Gui Y; Li C; Lin J; Gober HJ; Qin J; Li D; Wang L
Biosci Trends; 2017 Mar; 11(1):69-76. PubMed ID: 28179599
[TBL] [Abstract][Full Text] [Related]
20. The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis.
Lai NL; Zhang SX; Wang J; Zhang JQ; Wang CH; Gao C; Li XF
J Immunol Res; 2019; 2019():1058738. PubMed ID: 31772947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
